Report overview
A Bispecific Antibodies is designed to bind two different targets or epitopes and can thereby exert two different functions. They are currently used to treat infectious, inflammatory, and malignant diseases.
This report aims to provide a comprehensive presentation of the global market for T-Cell & NK-Cell Engaging Bispecific Antibodies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding T-Cell & NK-Cell Engaging Bispecific Antibodies. This report contains market size and forecasts of T-Cell & NK-Cell Engaging Bispecific Antibodies in global, including the following market information:
Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five T-Cell & NK-Cell Engaging Bispecific Antibodies companies in 2022 (%)
The global T-Cell & NK-Cell Engaging Bispecific Antibodies market was valued at US$ 485.7 million in 2022 and is projected to reach US$ 4927.4 million by 2029, at a CAGR of 39.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global key players of T-Cell & NK-Cell engaging bispecific antibodies include Amgen and Immunocore. These two manufactures hold the total market share in the world. The key players are mainly located in Europe and North America. In terms of product, T-Cell engagers is the largest segment, with a share over 93%. And in terms of application, the largest application is solid tumors, with a share over 71%.
We surveyed the T-Cell & NK-Cell Engaging Bispecific Antibodies manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Segment Percentages, by Type, 2022 (%)
T-Cell Engagers
NK-Cell Engagers
Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Segment Percentages, by Application, 2022 (%)
Hematological Cancers
Solid Tumors
Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global T-Cell & NK-Cell Engaging Bispecific Antibodies Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies T-Cell & NK-Cell Engaging Bispecific Antibodies revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies T-Cell & NK-Cell Engaging Bispecific Antibodies revenues share in global market, 2022 (%)
Key companies T-Cell & NK-Cell Engaging Bispecific Antibodies sales in global market, 2018-2023 (Estimated), (K Units)
Key companies T-Cell & NK-Cell Engaging Bispecific Antibodies sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
Immunocore
Johnson & Johnson
Roche
Pfizer
AbbVie
MacroGenics
Regeneron
Outline of Major Chapters:
Chapter 1: Introduces the definition of T-Cell & NK-Cell Engaging Bispecific Antibodies, market overview.
Chapter 2: Global T-Cell & NK-Cell Engaging Bispecific Antibodies market size in revenue and volume.
Chapter 3: Detailed analysis of T-Cell & NK-Cell Engaging Bispecific Antibodies manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of T-Cell & NK-Cell Engaging Bispecific Antibodies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global T-Cell & NK-Cell Engaging Bispecific Antibodies capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
